• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与重组人骨形态发生蛋白-2用于长骨不愈合相关的软组织肿胀

Soft Tissue Swelling Associated with the Use of Recombinant Human Bone Morphogenetic Protein-2 in Long Bone Non-unions.

作者信息

Young Andrew, Mirarchi Adam

机构信息

Department of Anesthesia & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, USA.

Department of Orthopedics & Rehabilitation, Oregon Health & Science University, Portland, Oregon, USA.

出版信息

J Orthop Case Rep. 2015 Jul-Sep;5(3):18-21. doi: 10.13107/jocr.2250-0685.297.

DOI:10.13107/jocr.2250-0685.297
PMID:27299059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4719390/
Abstract

This report describes two cases of long bone non-union associated with the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) and is the first of its kind. The first case describes a 25-year-old male who sustained a left diaphyseal femoral shaft fracture initially treated with operative fixation using an intramedullary nail, which subsequently loosened distally and was treated with exchange nailing and rhBMP-2 application. This patient developed acute local soft tissue inflammation post-operatively. The second case describes a 61-year-old female who sustained a right diaphyseal humeral shaft fracture that was initially treated with intramedullary nail fixation with subsequent distal interlock screw loosening. She underwent nail removal, and compression plating with rhBMP-2 placement, and postoperatively developed severe acute local tissue swelling centered over the rhBMP-2 sponge. Surgeons should be aware that rhBMP-2 may cause local acute tissue swelling and recombinant bone morphogenic proteins such as rhBMP-2 may have a role in the management for atrophic fracture non-unions. The authors recommend careful consideration prior to rhBMP-2 use in long bone non-unions.

摘要

本报告描述了两例与使用重组人骨形态发生蛋白-2(rhBMP-2)相关的长骨不愈合病例,此类报告尚属首次。第一例为一名25岁男性,其左股骨干骨折,最初采用髓内钉手术固定治疗,随后远端髓内钉松动,遂行更换髓内钉并应用rhBMP-2治疗。该患者术后出现急性局部软组织炎症。第二例为一名61岁女性,其右肱骨干骨折,最初采用髓内钉固定治疗,随后远端交锁螺钉松动。她接受了取出髓内钉、加压钢板固定并放置rhBMP-2治疗,术后在rhBMP-2海绵部位出现严重的急性局部组织肿胀。外科医生应意识到,rhBMP-2可能会导致局部急性组织肿胀,且诸如rhBMP-2等重组骨形态发生蛋白可能在萎缩性骨折不愈合的治疗中发挥作用。作者建议在长骨不愈合中使用rhBMP-2之前应谨慎考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/55ab1ae3ffa5/JOCR-5-18-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/2fdc200056f8/JOCR-5-18-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/a54bc86f61fc/JOCR-5-18-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/74b9a3b3e481/JOCR-5-18-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/4e4df4376f32/JOCR-5-18-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/ff8f599bd7e3/JOCR-5-18-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/93923daa0da9/JOCR-5-18-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/55ab1ae3ffa5/JOCR-5-18-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/2fdc200056f8/JOCR-5-18-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/a54bc86f61fc/JOCR-5-18-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/74b9a3b3e481/JOCR-5-18-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/4e4df4376f32/JOCR-5-18-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/ff8f599bd7e3/JOCR-5-18-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/93923daa0da9/JOCR-5-18-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/389d/4719390/55ab1ae3ffa5/JOCR-5-18-g007.jpg

相似文献

1
Soft Tissue Swelling Associated with the Use of Recombinant Human Bone Morphogenetic Protein-2 in Long Bone Non-unions.与重组人骨形态发生蛋白-2用于长骨不愈合相关的软组织肿胀
J Orthop Case Rep. 2015 Jul-Sep;5(3):18-21. doi: 10.13107/jocr.2250-0685.297.
2
Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation.重组人骨形态发生蛋白-2:经扩髓钉固定治疗开放性胫骨骨折的随机试验。
J Bone Joint Surg Am. 2011 May 4;93(9):801-8. doi: 10.2106/JBJS.I.01763. Epub 2011 Mar 31.
3
[Intramedullary fixation of humerus shaft fractures. An analysis of complications of 2 implants with special reference to outcome after management with the unreamed humerus interlocking nail].肱骨干骨折的髓内固定。两种植入物并发症分析,特别提及非扩髓肱骨交锁髓内钉治疗后的结果
Wien Klin Wochenschr. 2001 Aug 16;113(15-16):597-604.
4
Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial.重组人骨形态发生蛋白-2/磷酸钙基质治疗闭合性胫骨骨干骨折的疗效和安全性:一项双盲、随机、对照的 II/III 期试验。
J Bone Joint Surg Am. 2013 Dec 4;95(23):2088-96. doi: 10.2106/JBJS.L.01545.
5
Effectiveness of exchange K-nail and augmented plating in aseptic femoral diaphyseal non-union.交锁髓内钉与增强钢板治疗股骨骨干无菌性骨不连的疗效
Injury. 2017 Aug;48 Suppl 2:S61-S65. doi: 10.1016/S0020-1383(17)30496-5.
6
Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies.重组人骨形态发生蛋白-2用于开放性胫骨骨折。两项前瞻性随机研究合并数据的亚组分析。
J Bone Joint Surg Am. 2006 Jun;88(6):1258-65. doi: 10.2106/JBJS.E.00499.
7
Comparative study suggests that human bone morphogenetic proteins have no influence on the outcome of operative treatment of aseptic clavicle non-unions.对比研究表明,人骨形态发生蛋白对无菌性锁骨骨不连的手术治疗结果没有影响。
Int Orthop. 2016 Nov;40(11):2339-2345. doi: 10.1007/s00264-016-3262-8. Epub 2016 Aug 13.
8
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.重组人骨形态发生蛋白-2治疗开放性胫骨骨折:450例患者的前瞻性、对照、随机研究
J Bone Joint Surg Am. 2002 Dec;84(12):2123-34. doi: 10.2106/00004623-200212000-00001.
9
The treatment of atrophic, recalcitrant long-bone nonunion in the upper extremity with human recombinant bone morphogenetic protein-7 (rhBMP-7) and plate fixation: A retrospective review.应用人重组骨形态发生蛋白-7(rhBMP-7)和钢板固定治疗上肢萎缩性、顽固性长骨骨不连:一项回顾性研究。
Injury. 2016 Feb;47(2):356-63. doi: 10.1016/j.injury.2015.11.035. Epub 2015 Nov 27.
10
Effect of Bone Morphogenetic Protein-2 in the Treatment of Long Bone Non-Unions.骨形态发生蛋白-2在治疗长骨骨不连中的作用
J Clin Med. 2021 Oct 6;10(19):4597. doi: 10.3390/jcm10194597.

引用本文的文献

1
A Retrospective Study on Mandibular Reconstruction Following Excision of Canine Acanthomatous Ameloblastoma.犬牙棘皮瘤型成釉细胞瘤切除术后下颌骨重建的回顾性研究
Front Vet Sci. 2022 May 11;9:900031. doi: 10.3389/fvets.2022.900031. eCollection 2022.
2
Clinical Application of Bone Marrow Mesenchymal Stem/Stromal Cells to Repair Skeletal Tissue.骨髓间充质干细胞/基质细胞在修复骨骼组织中的临床应用。
Int J Mol Sci. 2020 Dec 21;21(24):9759. doi: 10.3390/ijms21249759.
3
Characterization of Naturally Occurring Bioactive Factor Mixtures for Bone Regeneration.

本文引用的文献

1
Exaggerated inflammatory response and bony resorption from BMP-2 use in a pediatric forearm nonunion.在小儿前臂骨不连中使用骨形态发生蛋白-2引发的过度炎症反应和骨质吸收。
J Hand Surg Am. 2012 Feb;37(2):316-21. doi: 10.1016/j.jhsa.2011.10.007. Epub 2011 Nov 25.
2
Folly of FDA-approval studies for bone morphogenetic protein.美国食品药品监督管理局批准的骨形态发生蛋白研究的荒谬之处
Spine J. 2011 Jun;11(6):495-9. doi: 10.1016/j.spinee.2011.05.009.
3
A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
用于骨再生的天然存在的生物活性因子混合物的表征
Int J Mol Sci. 2020 Feb 19;21(4):1412. doi: 10.3390/ijms21041412.
脊柱外科中重组人骨形态发生蛋白-2 试验的批判性评价:新出现的安全性问题和经验教训。
Spine J. 2011 Jun;11(6):471-91. doi: 10.1016/j.spinee.2011.04.023.
4
Physican-directed (off-label) use of recombinant bone morphogenic protein-2: let us do it well!
Spine J. 2011 Jun;11(6):469-70. doi: 10.1016/j.spinee.2011.04.005.
5
A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors.脊柱出版物诚信面临的挑战:多年来在推广骨生长因子方面险象环生。
Spine J. 2011 Jun;11(6):463-8. doi: 10.1016/j.spinee.2011.06.001.
6
An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.对重组人骨形态发生蛋白-2(rhBMP-2)用于前路脊柱椎间融合术风险的认识不断演变。
Spine J. 2011 Jun;11(6):520-1. doi: 10.1016/j.spinee.2011.04.019. Epub 2011 May 25.
7
High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo.大剂量骨形态发生蛋白 2 会在体内诱导结构异常的骨骼和炎症。
Tissue Eng Part A. 2011 May;17(9-10):1389-99. doi: 10.1089/ten.TEA.2010.0555. Epub 2011 Mar 3.
8
Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion.经皮椎间孔腰椎体间融合术后,重组骨形态发生蛋白-2 引起的组织病理学炎症反应导致根性病变。
Spine J. 2010 Sep;10(9):e1-6. doi: 10.1016/j.spinee.2010.06.020.
9
Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?在微创腰椎体间稳定术中应用低剂量骨形态发生蛋白-2 促进融合——但代价是什么?
Spine J. 2011 Jun;11(6):527-33. doi: 10.1016/j.spinee.2010.07.005. Epub 2010 Aug 24.
10
Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.经椎间孔腰椎体间融合术使用重组人骨形态发生蛋白-2 超适应证治疗后出现症状性异位骨形成。
J Neurosurg Spine. 2010 Jan;12(1):40-6. doi: 10.3171/2009.4.SPINE0876.